Beth Han, Wilson M Compton, Christopher M Jones, Daniel T Stimson, Elizabeth T Barfield, Julie Frost Bellgowan, Jennifer A Hobin, Nora D Volkow
{"title":"County-Level Variation in Substance Use Disorder Service Utilization by Insurance Payers and Self-Pay in the United States.","authors":"Beth Han, Wilson M Compton, Christopher M Jones, Daniel T Stimson, Elizabeth T Barfield, Julie Frost Bellgowan, Jennifer A Hobin, Nora D Volkow","doi":"10.4088/JCP.26m16340","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objectives:</b> To examine county-level variations in and correlates of substance use disorders (SUDs) health service utilization by insurance payers (Medicaid, private insurance, and Medicare) and self-pay.</p><p><p><b>Methods:</b> Service utilization (the number of health care encounters, visits, admissions, or prescriptions) for SUDs was extracted from the Disease Expenditure 2017-2019 Project. We linked county-level data to drug overdose mortality rates and County Health Rankings, Area Health Resources Files, and Opioid Environment Policy Scan datasets. Descriptive and regression analyses were applied.</p><p><p><b>Results:</b> During 2017-2019, Medicaid (52.7%) and private insurance (32.3%) financed 85.0% of annual average SUD service expenditures examined, accounting for 50.6% of SUD service utilizations (in number). Across 3,143 counties, the average annual county-level number of SUD service utilizations was 5.2 (95% CI =5.1-5.3) per 1,000 county residents. Self-pay individuals had the highest average county-level number of SUD service utilizations (8.6, 95% CI =8.4-8.6 per 1,000 county residents), followed by Medicaid beneficiaries (6.9, 95% CI =6.6-7.1 per 1,000 county Medicaid enrollees) and those paid by private insurance (2.8, 95% CI =2.7-2.8 per 1,000 privately insured county residents). County-level percentage of uninsured adults was negatively associated with SUD service utilization overall (standardized β = -.45, the highest across examined variables, <i>P</i><.0001), accounting for 23.0% of its variance. SUD-related health care resource indicators explained 2.3%.</p><p><p><b>Conclusions:</b> Across all examined payers, Medicaid funded a disproportionate share-over 50%-of SUD service expenditures. Findings quantified the substantial impact of county-level adult uninsured rates on SUD health service utilization, highlighting the pivotal role of health insurance in supporting access to and utilization of SUD services.</p>","PeriodicalId":50234,"journal":{"name":"Journal of Clinical Psychiatry","volume":"87 3","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2026-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13352591/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4088/JCP.26m16340","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: To examine county-level variations in and correlates of substance use disorders (SUDs) health service utilization by insurance payers (Medicaid, private insurance, and Medicare) and self-pay.
Methods: Service utilization (the number of health care encounters, visits, admissions, or prescriptions) for SUDs was extracted from the Disease Expenditure 2017-2019 Project. We linked county-level data to drug overdose mortality rates and County Health Rankings, Area Health Resources Files, and Opioid Environment Policy Scan datasets. Descriptive and regression analyses were applied.
Results: During 2017-2019, Medicaid (52.7%) and private insurance (32.3%) financed 85.0% of annual average SUD service expenditures examined, accounting for 50.6% of SUD service utilizations (in number). Across 3,143 counties, the average annual county-level number of SUD service utilizations was 5.2 (95% CI =5.1-5.3) per 1,000 county residents. Self-pay individuals had the highest average county-level number of SUD service utilizations (8.6, 95% CI =8.4-8.6 per 1,000 county residents), followed by Medicaid beneficiaries (6.9, 95% CI =6.6-7.1 per 1,000 county Medicaid enrollees) and those paid by private insurance (2.8, 95% CI =2.7-2.8 per 1,000 privately insured county residents). County-level percentage of uninsured adults was negatively associated with SUD service utilization overall (standardized β = -.45, the highest across examined variables, P<.0001), accounting for 23.0% of its variance. SUD-related health care resource indicators explained 2.3%.
Conclusions: Across all examined payers, Medicaid funded a disproportionate share-over 50%-of SUD service expenditures. Findings quantified the substantial impact of county-level adult uninsured rates on SUD health service utilization, highlighting the pivotal role of health insurance in supporting access to and utilization of SUD services.
目的:检查保险支付者(医疗补助、私人保险和医疗保险)和自付的物质使用障碍(sud)卫生服务利用的县级变化及其相关性。方法:从2017-2019年疾病支出项目中提取sud的服务利用率(就诊次数、就诊次数、入院次数或处方次数)。我们将县级数据与药物过量死亡率和县卫生排名、地区卫生资源文件和阿片类药物环境政策扫描数据集联系起来。采用描述性和回归分析。结果:2017-2019年,医疗补助(52.7%)和私人保险(32.3%)为85.0%的年度平均SUD服务支出提供了资金,占SUD服务利用的50.6%(数量)。在3143个县中,每年平均县级SUD服务使用率为每1000个县居民5.2个(95% CI =5.1-5.3)。自付个人的平均县级SUD服务使用率最高(8.6,95% CI =8.4-8.6 / 1000名县居民),其次是医疗补助受益人(6.9,95% CI =6.6-7.1 / 1000名县医疗补助登记者)和私人保险支付者(2.8,95% CI =2.7-2.8 / 1000名私人保险县居民)。县级未参保成年人百分比与SUD服务总体利用率呈负相关(标准化β = - 0.45,在所有被检查的变量中最高)。结论:在所有被检查的支付者中,医疗补助资助了不成比例的份额-超过50%- SUD服务支出。研究结果量化了县级成人未参保率对SUD医疗服务利用的实质性影响,强调了医疗保险在支持SUD服务获取和利用方面的关键作用。
期刊介绍:
For over 75 years, The Journal of Clinical Psychiatry has been a leading source of peer-reviewed articles offering the latest information on mental health topics to psychiatrists and other medical professionals.The Journal of Clinical Psychiatry is the leading psychiatric resource for clinical information and covers disorders including depression, bipolar disorder, schizophrenia, anxiety, addiction, posttraumatic stress disorder, and attention-deficit/hyperactivity disorder while exploring the newest advances in diagnosis and treatment.